MRK
Merck & Co., Inc.
Stock
$148.69−0.09 (−0.06%)Close Sep 28, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $41.9B | −14.4% | 15.8% | 1.6% |
| Shareholders' equity (Q2 2026) | $41.9B |
|---|---|
| YoY | −14.4% |
| 5-year CAGR | 15.8% |
| 10-year CAGR | 1.6% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $52.6B | +13.6% |
| 2024 | $46.3B | +23.2% |
| 2023 | $37.6B | −18.3% |
| 2022 | $46.0B | +20.4% |
| 2021 | $38.2B | +50.8% |
| 2020 | $25.3B | −2.3% |
| 2019 | $25.9B | −3.0% |
| 2018 | $26.7B | −22.2% |
| 2017 | $34.3B | −14.3% |
| 2016 | $40.1B | −10.3% |
| 2015 | $44.7B | −8.2% |
| 2014 | $48.6B | −2.2% |
| 2013 | $49.8B | −6.1% |
| 2012 | $53.0B | −2.7% |
| 2011 | $54.5B | +0.3% |
| 2010 | $54.4B | −7.9% |
| 2009 | $59.1B | +214.8% |
| 2008 | $18.8B | −8.9% |
| 2007 | $20.6B | — |